SF 4500 Summary

• Creates Office of Cannabis Derivatives: Establishes a new state office with a commissioner appointed by the governor to regulate hemp products, medical cannabis, and industrial hemp under Minnesota Statutes chapter 342.

• Consolidates cannabis regulation: Transfers hemp regulation from the Department of Agriculture and medical cannabis regulation from the Department of Health to the new Office of Cannabis Derivatives.

• Regulates hemp and hemp-derived products: Allows sale of hemp products containing no more than 0.3% THC through licensed growers, processors, and retailers with standards for testing, labeling, and packaging.

• Maintains medical cannabis program: Continues the existing medical cannabis registry program for patients with qualifying conditions, allowing two registered manufacturers to produce and distribute medical cannabis through licensed distribution facilities.

• Establishes advisory council and task force: Creates a Cannabis Advisory Council and Task Force on Medical Cannabis Therapeutic Research to advise on policy and assess the impact of cannabis programs on public health and law enforcement.